Navigation Links
PETA and its international affiliates launch not-for-profit international science company
Date:10/1/2013

Norfolk, Vir. For more than a decade PETA and its affiliates overseas, have been the scientific leader among animal-protection organisations worldwide, providing the European Union (EU) and the Organisation for Economic Co-operation and Development (OECD) with technical expertise in modern, reliable, non-animal research and testing methods. Now, in a landmark move, PETA US, PETA UK and their European and Asian affiliates have combined their scientific resources to form the PETA International Science Consortium, Ltd (PISC), which will work with industry, private research facilities and regulatory bodies on developing strategies to promote and implement non-animal research methods at the national and international level. PISC scientists have a broad range of expertise in pharmaceutical development, molecular biology, biochemistry and genetics.

PISC will also fund the research and development of non-animal methods. To date, PISC members have provided more than $1.4 million toward the development and validation of non-animal tests for assessing chemical toxicity, carcinogenicity, skin sensitisation and irritation and disruption to hormonal systems. Tests replaced by these new methods include an archaic animal test in which corrosive and irritating chemicals were smeared onto rabbits' raw, abraded skin over a 14-day period; no painkillers were given to them during the test.

"PISC scientists will be at the table with government regulators and corporations to bring them up to speed on the newest non-animal test methods," says PISC Director Jessica Sandler. "By influencing national and international testing regulations and guidelines, PISC will help countries around the world shift more quickly to modern, humane science."

Today, to coincide with the launch of the consortium, PETA is pleased to announce that PISC has been accepted as an accredited stakeholder at the European Chemicals Agency (ECHA). ECHA oversees the largest chemical test program in the world the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) regulation that requires millions of animals to suffer in toxicity tests. As an accredited stakeholder, PISC will be granted access to international regulators and meetings relating to REACH to encourage the replacement of animals wherever possible.

Before it became incorporated, PISC was accepted as a stakeholder by the European Union Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM), an organisation that has a critical role in determining the scientific acceptance and regulatory use of non-animal testing methods within the EU as well as globally. PISC will work with and influence the policy of the EURL ECVAM and the International Council on Animal Protection in OECD Programmes (ICAPO).


'/>"/>

Contact: Tasgola Bruner
tasgolab@peta.org
770-518-1675
People for the Ethical Treatment of Animals
Source:Eurekalert

Related biology news :

1. Ultracold matter technology from CU and SRI International licensed to Boulders ColdQuanta
2. International Polar Year conference: From knowledge to action
3. Large international study finds memory in adults impacted by versions of 4 genes
4. International team uncovers new genes that shape brain size, intelligence
5. Southampton researchers lead 2 international projects to help people out of poverty
6. UCSD researchers: Where international climate policy has failed, grassroots efforts can succeed
7. Washington University receives $8 million to lead international childhood malnutrition effort
8. Early Bird Discounts Available on International Healthcare and Biotechnology Conferences, Save Up To $600 with Global Information
9. New HealthFocus® International Study Reveals Five Very Different Weight Management Consumers
10. OU scientists and international team deciper the genetic code of the tomato
11. Digicel Launches Worlds First Biometric Identification System For International Money Transfers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2017)... Feb. 2, 2017   TapImmune, Inc. ... company specializing in the development of innovative peptide ... of cancer and metastatic disease, announced today it ... manufacturing of a second clinical lot of TPIV ... receptor alpha. The manufactured vaccine product will be ...
(Date:1/30/2017)...   Invitae Corporation (NYSE: NVTA ... today announced that it will report its fourth quarter ... on Monday, February 13, 2017, and Invitae,s management team ... p.m. Eastern / 1:45 p.m. Pacific. ... financial results, guidance, and recent developments and will spend ...
(Date:1/24/2017)... PHILADELPHIA , Jan. 24, 2017  It ... a baby,s sock that monitors vital signs and ... instance, an infant,s oxygen saturation level drops. But ... undue alarm to parents, with no evidence of ... "These devices are marketed aggressively to parents of ...
Breaking Biology News(10 mins):
(Date:2/21/2017)... , ... February 21, 2017 , ... ... organizations to build connected digital health applications, announced a partnership with Redox, a ... to seamlessly connect to many clinical systems while keeping data secure in the ...
(Date:2/21/2017)... (PRWEB) , ... February 21, ... ... the Life -Sciences division, Treximo will pair its $200M operational capacity with ... consulting and project management in areas affecting quality and operational management. ...
(Date:2/21/2017)... NEW YORK , Feb. 21, 2017   ... US, an international IT solutions and managed services provider ... offering – Service Desk for Epic. The new service ... their internal Epic resources by giving physicians, nurses and ... IT specialists for tier-one support. This will allow hospital ...
(Date:2/20/2017)... MONTREAL , Feb. 20, 2017 /PRNewswire/ - BioAmber Inc. (NYSE: ... as President and CEO and Fabrice Orecchioni, the company,s COO, has ... as COO over the past four years, Fabrice has overseen the ... Sarnia and the management of the Mitsui JV.  Fabrice ... for the proposed China JV. ...
Breaking Biology Technology: